Skip to content

The Effectiveness of Chewing Gum in Influencing Capsule Endoscopy Transit Time

The Effectiveness of Improved Use of Chewing Gum in Influencing Capsule Endoscopy Transit Time: A Prospective Randomized, Controlled Pilot Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03815136
Acronym
CGCE
Enrollment
250
Registered
2019-01-24
Start date
2019-01-20
Completion date
2019-07-31
Last updated
2020-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric Transit Time, Small-bowel Transit Time

Brief summary

The purpose of this study is to determine the effect of chewing gum, during the first one hour of examination in patients undergoing CE for GTT and SBTT time and the proportion of cases with complete small bowel examination and gastroscopy intervention.

Detailed description

The participants will include patients who need to a capsule endoscopy (CE) in this unit. The investigators will include 200 participants who had a CE at our centre based on the gastric transit times. These will be randomly divided into two groups. The participants (chew chewing gum) and the controls (do not chew chewing gum).

Interventions

OTHERChewing Gum

Patients of CG group chewed one piece of sugarless gum for approximately 15 min every 30 min at the first hour of the examination.

OTHERControl

The control group will not chew chewing gum while undergoing capsule endoscopy

Sponsors

The First Affiliated Hospital of Zhejiang Chinese Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
DOUBLE (Investigator, Outcomes Assessor)

Masking description

The patients were instructed not to tell the endoscopist or the investigators about whether or not they used chewing gum before, during, or after the SBCE procedure.

Intervention model description

Patients aged 16-80 years who were scheduled to undergo the small bowel capsule endoscopy(SBCE).

Eligibility

Sex/Gender
ALL
Age
16 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Patients aged ≥18 years and \<80 years old presenting for capsule endoscopy. Obtained of written informed consent before the procedure.

Exclusion criteria

* Patients on motility enhancing and/or slowing drugs(narcotics/prokinetics) should stop these at least 7 days prior to the procedure. * Patients, who have proven or suspected obstruction of the bowel. * Patients, who have had prior small bowel and/or gastric surgery. * Patients, who have a dysphagia prohibiting. * Patients with diabetes mellitus and/or hypo-/hyper-thyroidism.

Design outcomes

Primary

MeasureTime frameDescription
gastric transit time1 hourthe time interval between the first gastric image and the first duodenal image
small bowel transit time8 hourThe time interval between the first duodenal images and the first caecal image

Secondary

MeasureTime frameDescription
Completion rate9 hoursthe capsule reaching the caecum
Diagnostic yield9 hoursthe total number of positive (diagnostic and suspicious) findings
Intervention rate1 hoursGastroscopy intervention after capsule endoscopy not through pylorus within 1hour

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 16, 2026